Across both Europe and USA, the majority of infants requiring intervention for Congenital Heart Disease currently undergo a sternotomy (open heart surgery) – a hugely invasive procedure with extensive post-surgical recovery and long-term risks of post-op damage/scarring.
Transforming cardiac intervention for neonates / infants
The Anchoring Sheath will allow more treatment choices for clinicians – supporting the growing number of hybrid procedures
The main beneficiaries of the increase in hybrid procedures are the neonates/infants and indirectly, the impact extends to their families, healthcare systems and medical professionals who will have access to less invasive tools and methods.
Across Europe and the USA… default intervention…
Reducing the healthcare burden of unnecessary sternotomy : in Europe, an approximate all-inclusive cost range is €15,000 – €70,000 – the variance is due to country/payer systems, disease complexity and ICU/ward length of stay. A similar range in USA is $32.000 – $120,000.
Average EU Cost
€0
–
€0
Average USA Cost
$0
–
$0
What are the key hybrid benefits?
Shorter hospital ICU time, reduced risk of infection/complications and huge reduction in scarring (both internal and cosmetic).
Obviously, beyond the base economics lies the significant quality of life benefits and the value in reducing trauma in a patient group that will often require repeated interventions throughout their adolescent and adult life.
A full cost/benefit analysis is currently under review and we look forward to publishing later this year.